如果把新药开发比喻成后台,产品营销看作前台,国外公司的思路是后台支持前台,而我们只能通过前台带动后台。 从全球来看,制药业竞争焦点主要是新药的开发能力和药品的营销。由于新药开发存在投入大(一个新药平均成本为5亿美元)、周期长和风险大的特点,虽然新药由知识产权门槛在全球范围赚取高 If the new drug development is compared to the background, product marketing as the front desk, the idea of ​​foreign companies is to support the front desk in the background, and we can only drive the background through the front desk. From a global perspective, the focus of competition in the pharmaceutical industry is mainly on the development capabilities of new drugs and the marketing of pharmaceuticals. Due to the large investment in new drug development (average cost of a new drug is 500 million US dollars), long cycle, and high risk, although the new drug is earning high global patent threshold